Overview
Join a Hidradenitis Suppurativa Research Study Near You
Everyone's experience is unique, and your participation matters. Join a clinical research study and contribute to advances in Hidradenitis Suppurativa (HS). We are seeking volunteers to participate in one of our clinical trials to help make a difference.
About this Study
A Maximal Use Trial of Ruxolitinib Cream in Adult and Adolescent Participants with Hidradenitis Suppurativa
Medical research helps doctors and scientists discover better treatments and improve healthcare for everyone. This Hidradenitis Suppurativa (HS) research study is investigating a potential treatment for HS.
By joining as a volunteer, you play a key role in making these important advancements possible.
Who Can Join
You may qualify if you:
- Are 12–75 years old
- Are diagnosed with Hidradenitis Suppurativa (HS) for at least 6 months
- Have at least 4 ACTIVE nodules in 3 areas of the body
- Have inflammation / redness over at least 20% of your body caused by the active nodules
- Have had an inadequate response to antibiotics for treatment of HS
- Agree not to use topical or systemic antibiotics for the treatment of HS, as well as topical antiseptics (including washes and leave-on products) with ingredients such as chlorhexidine gluconate, povidone iodine, sodium hypochlorite, diluted bleach, or benzoyl peroxide, on any areas affected by HS lesions during the study.
You may NOT qualify if you:
- Have active tuberculosis or hepatitis B or C
- Are Immunocompromised (eg, lymphoma, immunosuppression associated with organ transplantation, Wiskott-Aldrich syndrome)
- Have severe anemia, severe thrombocytopenia, or severe neutropenia.
- Have positive HIV
- Have failed treatment for HS using systemic or topical JAK inhibitor (eg, abrocitinib, baricitinib, brepocitinib, delgocitinib, filgotinib, lestaurtinib, pacritinib, ruxolitinib, tofacitinib,upadacitinib)
*Other conditions apply
Not sure if you qualify? That’s okay.
A member of our recruitment team will review your medical history and medications with you to see if this study may be right for you.
What to Expect
Study Duration:
Up to 24 weeks
Study Visits:
Up to 8 site visits
Compensation:
Participants may receive compensation up to $950